Effects of matrix metalloproteinase-1 on the myogenic differentiation of bone marrow-derived mesenchymal stem cells in vitro

Biochemical and Biophysical Research Communications

Volumn 428, Issue 2, 2012, Pages 309-314

  Zheng, Zhenyang ^a   Leng, Yan ^a   Zhou, Chen ^a   Ma, Zhenyu ^a   Zhong, Zhigang ^a   Shi, Xing Ming ^b   Zhang, Weixi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Bone marrow derived mesenchymal stem cells; Matrix metalloproteinase 1; Myogenesis

Indexed keywords

DESMIN; INTERSTITIAL COLLAGENASE; MESSENGER RNA; MYOD PROTEIN;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; BONE MARROW CELL; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL;

ADIPOGENESIS; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; DESMIN; MALE; MATRIX METALLOPROTEINASE 1; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MUSCLE DEVELOPMENT; MYOD PROTEIN; OSTEOGENESIS;

MUS;

EID: 84869204630     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.053     Document Type: Article

References (24)

1. Salem H.K., Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010, 28:585-596.
2. Chan J., O'Donoghue K., Gavina M., et al. Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. Stem Cells 2006, 24:1879-1891.
3. Gang E.J., Bosnakovski D., Simsek T., et al. Pax3 activation promotes the differentiation of mesenchymal stem cells toward the myogenic lineage. Exp. Cell Res. 2008, 314:1721-1733.
4. Wang W., Pan H., Murray K., et al. Matrix metalloproteinase-1 promotes muscle cell migration and differentiation. Am. J. Pathol. 2009, 174:541-549.
5. Zhang W., Ou G., Hamrick M., et al. Age-related changes in the osteogenic differentiation potential of mouse bone marrow stromal cells. J. Bone Miner. Res. 2008, 23:1118-1128.
6. Wong R.S. Mesenchymal stem cells: angels or demons?. J. Biomed. Biotechnol. 2011, 2011:459-510.
7. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
8. Rowlands A.S., George P.A., Cooper-White J.J. Directing osteogenic and myogenic differentiation of MSCs: interplay of stiffness and adhesive ligand presentation. Am. J. Physiol. Cell Physiol. 2008, 295:C1037-C1044.
9. Bernardo M.E., Cometa A.M., Pagliara D., et al. Ex vivo expansion of mesenchymal stromal cells. Best Pract. Res. Clin. Haematol. 2011, 24:73-81.
10. Chamberlain G., Fox J., Ashton B., et al. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25:2739-2749.
11. Perry R.L., Rudnick M.A. Molecular mechanisms regulating myogenic determination and differentiation. Front. Biosci. 2000, 5:D750-D767.
12. Berkes C.A., Tapscott S.J. MyoD and the transcriptional control of myogenesis. Semin. Cell Dev. Biol. 2005, 16:585-595.
13. Etzion S., Barbash I.M., Feinberg M.S., et al. Cellular cardiomyoplasty of cardiac fibroblasts by adenoviral delivery of MyoD ex vivo: an unlimited source of cells for myocardial repair. Circulation 2002, 106:I125-I130.
14. Capetanaki Y., Milner D.J., Weitzer G. Desmin in muscle formation and maintenance: knockouts and consequences. Cell Struct. Funct. 1997, 22:103-116.
15. Costa M.L., Escaleira R., Cataldo A., et al. Desmin: molecular interactions and putative functions of the muscle intermediate filament protein. Braz. J. Med. Biol. Res. 2004, 37:1819-1830.
16. Balana B., Nicoletti C., Zahanich I., et al. 5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells. Cell Res. 2006, 16:949-960.
17. Drost A.C., Weng S., Feil G., et al. In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair. Ann. N. Y. Acad. Sci. 2009, 1176:135-143.
18. Swarnakar S., Paul S., Singh L.P., et al. Matrix metalloproteinases in health and disease: regulation by melatonin. J. Pineal Res. 2011, 50:8-20.
19. Chen X., Li Y. Role of matrix metalloproteinases in skeletal muscle: migration, differentiation, regeneration and fibrosis. Cell Adh. Migr. 2009, 3:337-341.
20. Lewis M.P., Tippett H.L., Sinanan A.C., et al. Gelatinase-B (matrix metalloproteinase-9; MMP-9) secretion is involved in the migratory phase of human and murine muscle cell cultures. J. Muscle Res. Cell Motil. 2000, 21:223-233.
21. El F.E., Torrente Y., Caron N.J., et al. In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. Exp. Cell Res. 2000, 258:279-287.
22. Caron N.J., Asselin I., Morel G., et al. Increased myogenic potential and fusion of matrilysin-expressing myoblasts transplanted in mice. Cell Transplant. 1999, 8:465-476.
23. Kar S., Subbaram S., Carrico P.M., et al. Redox-control of matrix metalloproteinase-1: a critical link between free radicals, matrix remodeling and degenerative disease. Respir. Physiol. Neurobiol. 2010, 174:299-306.
24. Guilak F., Cohen D.M., Estes B.T., et al. Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell 2009, 5:17-26.